For millions of Americans with diabetes and prediabetes, reaching for a sugar-free candy bar, a "diabetic-friendly" cookie, or a stick of sugar-free gum feels like a safe choice — a way to satisfy the desire for sweetness while protecting blood sugar. New research from Washington University Medicine in St. Louis suggests that for some of these individuals, the reality may be more complicated, and the organ quietly bearing the cost may be their liver.
A study published in Science Signaling and highlighted in coverage by ScienceDaily, the Detroit News, and SciTechDaily found that sorbitol — one of the most widely used sugar alcohols in foods marketed as low-calorie or diabetes-appropriate — can trigger processes linked to metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as nonalcoholic fatty liver disease) in individuals whose gut bacteria cannot adequately break it down.
The mechanism is specific and concerning: sorbitol, when it exceeds the gut microbiome's capacity to degrade it, passes into the liver, where it is converted to a derivative of fructose. And fructose, as decades of research have established, is one of the most significant dietary drivers of fatty liver disease.
The Mechanism — From Sugar-Free Snack to Liver Fat
Senior author Gary Patti, professor of chemistry, genetics, and medicine at Washington University Medicine, explained the core finding to SciTechDaily: "The most surprising finding from the current work is that because sorbitol is essentially 'one transformation away from fructose,' it can induce similar effects."
Sorbitol is a sugar alcohol that occurs naturally in some fruits, including apples, pears, peaches, and plums, and is manufactured for use as a food additive. Its appeal as a sweetener rests on three properties: lower caloric density than table sugar, reduced impact on blood glucose levels compared to glucose, and a natural origin. For people with diabetes and prediabetes who must avoid blood sugar spikes, these properties make sorbitol-containing foods an attractive choice for managing the sweet tooth.
The problem lies in what happens to sorbitol in the body. Under normal conditions, as WashU Medicine's source coverage explains, gut bacteria — particularly certain strains of Aeromonas bacteria — efficiently degrade sorbitol in the intestine, converting it into harmless bacterial byproducts before it can reach the liver. When this degradation pathway is intact and functioning, sorbitol poses little liver risk.
But two scenarios overwhelm this protective mechanism:
Scenario 1 — Too much dietary sorbitol. When a person consumes large amounts of sorbitol through processed "sugar-free" foods (multiple servings of sugar-free candy, several sticks of sorbitol-containing gum, protein bars with sorbitol listed in the ingredients), the quantity can exceed what even a healthy gut microbiome can degrade, allowing excess sorbitol to pass to the liver.
Scenario 2 — Disrupted gut microbiome. When the gut microbiome is compromised — through antibiotic use, inflammatory bowel conditions, an ultra-processed food-heavy diet, chronic illness, or other factors — the bacterial strains responsible for sorbitol degradation may be absent or insufficient. Even moderate dietary sorbitol consumption can then pass to the liver in quantities sufficient to trigger metabolic harm.
| Sorbitol and Liver Disease — Key Data | Detail |
| Study published in | Science Signaling |
| Lead institution | Washington University Medicine, St. Louis |
| Senior author | Gary Patti, Professor of Chemistry, Genetics, and Medicine |
| Mechanism | Sorbitol → converted to fructose derivative in liver when gut bacteria overwhelmed |
| Protective mechanism | Certain Aeromonas gut bacteria degrade sorbitol harmlessly when present in adequate numbers |
| When protection fails | Excessive dietary sorbitol OR disrupted gut microbiome (antibiotics, illness, diet) |
| Disease triggered | MASLD (metabolic dysfunction-associated steatotic liver disease; formerly NAFLD) |
| MASLD global prevalence | ~30% of adults worldwide |
| High-risk populations | Type 2 diabetes; prediabetes; obesity; those with compromised gut microbiomes |
| Sorbitol found in | Sugar-free candies, chewing gum, protein bars, diabetic-marketed baked goods, reduced-sugar foods |
| Occurs naturally in | Stone fruits (apples, pears, peaches, plums) at modest levels |
| Also noted | Glucose consumption can drive endogenous sorbitol production, compounding dietary exposure |
Why Diabetics Are at Greatest Risk — and What MASLD Actually Does to the Liver
MASLD — excess fat accumulation in the liver due to metabolic dysfunction rather than alcohol consumption — affects an estimated 30% of adults worldwide and is strongly associated with obesity, insulin resistance, and type 2 diabetes. According to SciTechDaily's coverage, MASLD is increasingly being diagnosed in younger people, and it advances silently: most people have no symptoms until the disease has progressed toward cirrhosis or liver cancer.
This creates a particularly troubling irony for people with type 2 diabetes. The very condition that leads them to choose sorbitol-containing sugar-free foods — diabetes and insulin resistance — is also one of the strongest risk factors for MASLD. They are the demographic most likely to have a compromised gut microbiome (from medications including metformin, repeated antibiotic courses, and the inflammatory effects of metabolic disease itself), most likely to be consuming large quantities of sorbitol-containing foods as substitutes for sugar, and most likely to have liver vulnerability that sorbitol-driven fat accumulation would worsen.
As The Brighter Side of News noted in its coverage: "For people with diabetes or metabolic disorders, sugar substitutes are often a lifeline. Many rely on sorbitol-sweetened foods to avoid sharp jumps in blood glucose. But the study raises urgent questions about whether heavy use of sorbitol may shift the burden from blood sugar control to liver health."
Patti was direct about the challenge this creates: "Avoiding both sugar and alternative sweeteners is increasingly complicated, as many foods are packed with multiple varieties of all the above."
What Diabetics and Their Care Providers Should Do
The research does not establish that moderate, occasional sorbitol consumption causes liver disease in healthy individuals with intact gut microbiomes — the mechanism requires either excessive intake or microbiome disruption to become pathological. Sorbitol in the small amounts present in natural fruits is not a clinical concern.
The specific risk sits in the concentrated amounts found in sugar-free processed foods, particularly for heavy users — people who consume multiple servings of sorbitol-containing products daily as a primary sugar management strategy.
Practical guidance for people with diabetes and prediabetes:
- Read ingredient labels on all products marketed as "sugar-free," "reduced sugar," or "diabetic-friendly" for sorbitol content
- Moderate rather than maximize consumption of sorbitol-containing processed foods — these are not unconditionally safer than small amounts of natural sugar in whole food contexts
- Be aware of antibiotic effects — any course of antibiotics may temporarily reduce gut sorbitol-degrading bacteria, increasing the risk window
- Discuss sweetener choices with your endocrinologist or primary care provider — particularly if you have established MASLD, metabolic dysfunction, or compromised gut health
- Prioritize whole food sweetness sources — natural fruits at modest quantities provide sorbitol at levels gut bacteria can generally handle, while also providing fiber, antioxidants, and vitamins
Frequently Asked Questions
What did the sorbitol and liver disease study find?
A study published in Science Signaling by Washington University Medicine found that sorbitol — a sugar alcohol widely used in sugar-free and "diabetic-friendly" foods — can trigger fatty liver disease (MASLD) by converting to fructose in the liver when gut bacteria are unable to degrade it adequately. Senior author Gary Patti described sorbitol as "one transformation away from fructose," producing similar metabolic liver effects under the right conditions.
Who is most at risk?
People who consume large quantities of sorbitol-containing sugar-free products AND/OR have a compromised gut microbiome face the greatest risk. People with type 2 diabetes and prediabetes are particularly vulnerable — they are both the heaviest users of sorbitol-containing foods and more likely to have metabolic conditions and gut microbiome disruptions that reduce sorbitol-degrading bacterial capacity.
Does this mean all sugar-free food is dangerous?
No. The risk is specific to excessive sorbitol consumption or to consumption when gut bacteria are insufficient to degrade it. Sorbitol at levels found in natural fruits is not a clinical concern. The issue is concentrated amounts found in multiple servings of sugar-free processed foods consumed heavily over time.
What is MASLD?
Metabolic dysfunction-associated steatotic liver disease (MASLD) — formerly called non-alcoholic fatty liver disease (NAFLD) — is excess fat accumulation in the liver due to metabolic dysfunction rather than alcohol. It affects approximately 30% of adults worldwide, advances with few symptoms, and can progress to cirrhosis or liver cancer.
What should people with diabetes do with this information?
Read ingredient labels for sorbitol content in sugar-free products. Moderate rather than maximize consumption of sorbitol-containing processed foods. Discuss sweetener choices with your endocrinologist, particularly if you have MASLD, metabolic dysfunction, or recently used antibiotics. Prioritize whole food sweetness sources and consult your care team before making major dietary changes.
